Jens Bichel

Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion

Wolfram Sterry, Thomas Ruzicka, E. Herrera et al. · British Journal of Dermatology · 2002 · 192 citations

Imiquimod 5% cream for the treatment of actinic keratosis: Results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology

Rolf‐Markus Szeimies, Marie‐Jeanne P. Gerritsen, G. Gupta et al. · Journal of the American Academy of Dermatology · 2004 · 192 citations

Ophthalmology, Imiquimod 5, Phase Iii +6

Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients

Claas Ulrich, Jens Bichel, Sylvie Euvrard et al. · British Journal of Dermatology · 2007 · 159 citations · Full text

Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the head

Agustı́n Alomar, Jens Bichel, Scott McRae · British Journal of Dermatology · 2007 · 118 citations

A phase II dose-ranging study of topical resiquimod to treat actinic keratosis

Rolf‐Markus Szeimies, Jens Bichel, J P Ortonne et al. · British Journal of Dermatology · 2008 · 91 citations